Chief Medical Officer Hendrik Scholl said the company is advancing its lead compound, Tinlarebant, as a potential treatment ...
Yes, Jim Cramer has said a lot of things about a lot of stocks over the years. But when the "Mad Money" host identifies a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results